Literature DB >> 19250854

PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease.

Alexander Zimprich1, Claudia Schulte, Eva Reinthaler, Dietrich Haubenberger, Jörg Balzar, Peter Lichtner, Salwa El Tawil, S Edris, Thomas Foki, Walter Pirker, Regina Katzenschlager, Gerhard Daniel, Thomas Brücke, Eduard Auff, Thomas Gasser.   

Abstract

The GIGYF2 (Grb10-Interacting GYF Protein-2) gene has recently been proposed to be the responsible gene for the PARK11 locus. Ten different putative pathogenic variants were identified in cohorts of Parkinson's disease (PD) patients from Italy and France. Among these variants Asn56Ser and Asn457Thr were found repeatedly. In the present study we screened 669 PD patients (predominantly of central European origin) and 1051 control individuals for the presence of these two variants. Asn56Ser was found in one patient with a positive family history of the disease and in one control individual. The affected sister of the patient did not carry this variant. Asn457Thr was found in one patient, who was exceptional for his Egyptian origin and in three control individuals. This variant was not found in 50 control individuals from Egypt. We conclude that neither of these two variants plays a major role in the pathogenesis of PD in our study population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19250854     DOI: 10.1016/j.parkreldis.2009.01.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

1.  The contribution of GIGYF2 to Parkinson's disease: a meta-analysis.

Authors:  Yuan Zhang; Qi-Ying Sun; Ren-He Yu; Ji-Feng Guo; Bei-Sha Tang; Xin-Xiang Yan
Journal:  Neurol Sci       Date:  2015-07-08       Impact factor: 3.307

Review 2.  Genetics of Parkinson disease and essential tremor.

Authors:  Christian Wider; Owen A Ross; Zbigniew K Wszolek
Journal:  Curr Opin Neurol       Date:  2010-08       Impact factor: 5.710

3.  Meta-analyses of seven GIGYF2 polymorphisms with Parkinson's disease.

Authors:  Dongjun Dai; Yunliang Wang; Xingyu Zhou; Jianmin Tao; Danjie Jiang; Hanlin Zhou; Yi Jiang; Guanghui Pan; Ping Ru; Huihui Ji; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Mingqing Xu; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-07-31

4.  Non-synonymous GIGYF2 variants in Parkinson's disease from two Asian populations.

Authors:  Eng-King Tan; Chin-Hslen Lin; Chun-Hwei Tai; Louis C Tan; Meng-Ling Chen; R Li; Hui-Qin Lim; Ratnagopal Pavanni; Yih Yuen; K M Prakash; Yi Zhao; Ruey-Meei Wu
Journal:  Hum Genet       Date:  2009-05-16       Impact factor: 4.132

5.  GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling.

Authors:  Barbara Giovannone; William G Tsiaras; Suzanne de la Monte; Jan Klysik; Corinne Lautier; Galina Karashchuk; Stefano Goldwurm; Robert J Smith
Journal:  Hum Mol Genet       Date:  2009-09-10       Impact factor: 6.150

6.  Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.

Authors:  Prabhjyot Saini; Uladzislau Rudakou; Eric Yu; Jennifer A Ruskey; Farnaz Asayesh; Sandra B Laurent; Dan Spiegelman; Stanley Fahn; Cheryl Waters; Oury Monchi; Yves Dauvilliers; Nicolas Dupré; Lior Greenbaum; Sharon Hassin-Baer; Alberto J Espay; Guy A Rouleau; Roy N Alcalay; Edward A Fon; Ronald B Postuma; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2020-10-31       Impact factor: 4.673

7.  Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.

Authors:  Claudia Schulte; Thomas Gasser
Journal:  Appl Clin Genet       Date:  2011-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.